These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8324143)

  • 21. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA; Castillo AM; Liébana J; Marín A; Alados JC; Piédrola G
    J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):189-97. PubMed ID: 1940333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial effect of beta-lactam antibiotic combinations against Bacteroides fragilis in vitro.
    Bansal MB; Thadepalli H
    Antimicrob Agents Chemother; 1983 Jan; 23(1):166-8. PubMed ID: 6830206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increase in the activity of third-generation cephalosporins in combination with clavulanic acid and Sulbactam against Bacteroides fragilis.
    Martín MA; Castillo AM; Liebana J; Mesa P; Piedrola G; Gutierrez J
    Med Lab Sci; 1990 Jul; 47(3):163-7. PubMed ID: 2402195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on beta-lactamase in Bacteroides fragilis.
    Nord CE; Dornbusch K; Olsson B
    Infection; 1980; 8 Suppl 2():S167-70. PubMed ID: 6969692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. beta-lactamases in bacteroides.
    Nord CE; Olsson B; Dornbusch K
    Scand J Infect Dis Suppl; 1978; (13):27-32. PubMed ID: 28561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.
    Fang H; Edlund C; Hedberg M; Nord CE
    Int J Antimicrob Agents; 2002 May; 19(5):361-70. PubMed ID: 12007843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.
    Tanaka-Bandoh K; Kato N; Watanabe K; Ueno K
    Clin Infect Dis; 1995 Jun; 20 Suppl 2():S352-5. PubMed ID: 7548596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. R-plasmid mediated transfer of beta-lactam resistance in Bacteroides fragilis.
    Yamaoka K; Watanabe K; Muto Y; Katoh N; Ueno K; Tally FP
    J Antibiot (Tokyo); 1990 Oct; 43(10):1302-6. PubMed ID: 2258328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activities of GSK2251052, a novel boron-containing leucyl-tRNA synthetase inhibitor, against 916 anaerobic organisms.
    Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
    Antimicrob Agents Chemother; 2013 May; 57(5):2401-4. PubMed ID: 23459482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contribution of beta-lactamases to beta-lactam resistance in Bacteroides fragilis.
    Simpson IN; Page CD; Harper PB
    J Antimicrob Chemother; 1982 Jan; 9(1):29-45. PubMed ID: 6977524
    [No Abstract]   [Full Text] [Related]  

  • 31. Early susceptibility test results with the Bacteroides fragilis group.
    Aldridge KE
    J Antimicrob Chemother; 1993 Dec; 32(6):910-2. PubMed ID: 8144437
    [No Abstract]   [Full Text] [Related]  

  • 32. Multicentre survey in France of the antimicrobial susceptibilities of 416 blood culture isolates of the Bacteroides fragilis group.
    Patey O; Varon E; Prazuck T; Podglajen I; Dublanchet A; Dubreuil L; Breuil J
    J Antimicrob Chemother; 1994 May; 33(5):1029-34. PubMed ID: 8089049
    [No Abstract]   [Full Text] [Related]  

  • 33. Emergence of fluoroquinolone resistance in Bacteroides fragilis accompanied by resistance to beta-lactam antibiotics.
    Kato N; Miyauchi M; Muto Y; Watanabe K; Ueno K
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1437-8. PubMed ID: 2848446
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.
    Wise R; Gillett AP; Andrews JM
    J Antimicrob Chemother; 1979 May; 5(3):301-6. PubMed ID: 113377
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparative in-vitro activity of cefoperazone/sulbactam and 11 other agents against multidrug resistant Bacteroides fragilis group species.
    Goldstein EJ; Citron DM
    J Antimicrob Chemother; 1996 Oct; 38(4):733-7. PubMed ID: 8937969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
    Maskell JP; Nasu M; Williams JD
    J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.
    Cuchural GJ; Tally FP; Jacobus NV; Cleary T; Finegold SM; Hill G; Iannini P; O'Keefe JP; Pierson C
    Antimicrob Agents Chemother; 1990 Mar; 34(3):479-80. PubMed ID: 2334161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activities of MK-0826 and 16 other antimicrobials against Bacteroides fragilis group strains.
    Betriu C; Sánchez A; Palau ML; Gómez M; Picazo JJ
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2372-4. PubMed ID: 11451700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to beta-lactam antibiotics and beta-lactamase production of Bacteroides, Porphyromonas and Prevotella strains.
    Nagy E; Szóke I; Gacs M; Csiszár K
    Acta Microbiol Immunol Hung; 1995; 42(3):287-99. PubMed ID: 8548202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
    Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
    J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.